or Try an Advanced Search...

    ETF Components for XPH - SPDR S&P Pharmaceuticals ETF


    Below is a list of stocks held by this ETF. We only list holdings in the same market. If this is a global ETF, there may be additional components other than those listed here.

    Holdings

    Symbol Grade Price % Change Allocation
    AXSM B 1.62 4.15
    ITCI C 0.77 4.14
    LLY B -0.95 3.99
    MRK C -1.46 3.97
    BMY F -0.96 3.96
    PFE D -0.47 3.94
    OGN C 0.94 3.94
    CTLT B 0.55 3.92
    VTRS F -0.48 3.92
    JNJ F -0.23 3.91
    RPRX F 0.15 3.87
    ELAN F 0.86 3.83
    ZTS C 0.45 3.81
    JAZZ F -1.48 3.71
    PRGO D 0.77 3.69
    CORT C -3.36 3.34
    ARVN F -3.82 3.07
    PBH C -1.41 2.43
    OCUL C 0.15 2.25
    AMPH F 2.61 2.24
    SAVA F -8.65 2.08
    PCRX F -4.75 2.02
    SUPN F 0.93 1.94
    COLL D 1.00 1.91
    TARS D 5.01 1.85
    LGND B -2.46 1.58
    HRMY B 2.97 1.54
    EWTX C -0.54 1.47
    ANIP D -2.91 1.46
    LQDA D 1.10 1.40
    INVA B -1.03 1.20
    MNMD D 2.59 1.16
    LBPH B 3.81 1.13
    AMRX C 3.05 1.08
    EOLS D 3.10 0.97
    EYPT F 7.62 0.83
    HROW B 3.62 0.81
    ELVN C -0.69 0.66
    PLRX F -0.19 0.61
    FULC F 0.90 0.50
    NUVB D -1.68 0.47
    XERS C 0.97 0.39
    WVE D 1.92 0.37

    Represented by ETF Holdings

    Keywords: Biopharmaceutical Pharmaceutical Medicine Pharmaceutical Products Pain S&P 500 Alzheimer's Disease Animal Health Biotechnology Depression Diabetes Disease Drugs Hypertension Life Sciences Neuroscience Pharmacology Suspension Antibiotics Cancer
    Industries: Biotechnology Drug Manufacturers - Specialty & Generic Drug Manufacturers - Major Drug Manufacturers - General Medical Distribution

    Recent News for SPDR S&P Pharmaceuticals ETF & its Holdings

    Date Stock Title
    Jul 3 PCRX Pacira downgraded at Barclays following generic Exparel approval
    Jul 3 LLY Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
    Jul 3 XERS Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
    Jul 3 LLY S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
    Jul 3 LLY Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
    Jul 3 LLY Weight-loss drugs linked to rare vision loss: Harvard study
    Jul 3 LLY ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
    Jul 3 LLY Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
    Jul 3 LLY FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
    Jul 3 MRK Merck: Among The Best Health Care GARP Plays Today
    Jul 3 PFE GSK Will Pay Up to $1.5 Billion for CureVac’s mRNA Vaccines
    Jul 3 JNJ Johnson & Johnson: A Lot Of Moving Parts, But Perhaps Finally Lurching In The Right Direction
    Jul 3 JNJ Johnson & Johnson: Put Selling Can Yield A Potential 9.8% Return
    Jul 3 LLY Top 3 Health Care Stocks That May Crash This Quarter
    Jul 3 HROW Top 3 Health Care Stocks That May Crash This Quarter
    Jul 3 LBPH Top 3 Health Care Stocks That May Crash This Quarter
    Jul 3 PFE Pfizer (PFE) Stock Falls in a Year: Time to Buy, Sell or Hold?
    Jul 3 PFE Health Care Stocks With A Long History Of Dividend Growth And Solid Yields
    Jul 3 LLY Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
    Jul 3 VTRS Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture
    The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "index"), the fund employs a replication strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the pharmaceuticals industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.
    Exchange Traded Fund ETF Index Fund S&P Top 100 Loan Index Pharmaceuticals Segment
    Back to the Main XPH Page...